Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
RSC Medicinal Chemistry
|
September 30, 2024
Asymmetric imidazole-4,5-dicarboxamide derivatives as SARS-CoV-2 main protease inhibitors: design, synthesis and biological evaluation
Phuong Nguyen Hoai Huynh, Phatcharin Khamplong, Minh-Hoang Phan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2023
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma
Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail, et al.
Nature Communications
|
May 3, 2020
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
Xian-De Liu, Wen Kong, Christine B Peterson, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 11, 2025
Enhancing vaccine acceptance: a mixed methods approach to health promotion and willingness to pay among low-income Vietnamese communities
Quang Vinh Tran, Tram Thi Huyen Nguyen, Hiep Thanh Nguyen, et al.
Cancer Research
|
June 18, 2026
Aerobic Exercise Activates S1PR1 Signaling in Tumor Endothelial Cells to Promote Vascular Function in Pancreatic Cancer
Riccardo BallarĂ², Truong Lam, Sumedha Pareek, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
RSC Medicinal Chemistry
|
September 30, 2024
Asymmetric imidazole-4,5-dicarboxamide derivatives as SARS-CoV-2 main protease inhibitors: design, synthesis and biological evaluation
Phuong Nguyen Hoai Huynh, Phatcharin Khamplong, Minh-Hoang Phan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2023
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma
Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail, et al.
Nature Communications
|
May 3, 2020
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
Xian-De Liu, Wen Kong, Christine B Peterson, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 11, 2025
Enhancing vaccine acceptance: a mixed methods approach to health promotion and willingness to pay among low-income Vietnamese communities
Quang Vinh Tran, Tram Thi Huyen Nguyen, Hiep Thanh Nguyen, et al.
Cancer Research
|
June 18, 2026
Aerobic Exercise Activates S1PR1 Signaling in Tumor Endothelial Cells to Promote Vascular Function in Pancreatic Cancer
Riccardo BallarĂ², Truong Lam, Sumedha Pareek, et al.
Page
of 2